Tirzepatide duration of action: how long each dose stays active

Step 1: what happens in your body in the first 24–48 hours after an injection

After you inject tirzepatide into the abdomen, thigh, or upper arm, it is absorbed from the subcutaneous tissue into the bloodstream over roughly one to two days. Peak plasma concentration (the point at which levels are highest in the blood) is typically reached around 8–72 hours post-injection, though this varies between individuals. During this window, the dual agonist activity on GIP and GLP-1 receptors is at its most intense: appetite suppression, slowing of gastric emptying, and the associated shift in how full you feel after eating are all most pronounced here.

This is also the phase when the most commonly reported side effects tend to surface. Nausea, some digestive discomfort, or a general sense of queasiness are most frequent in the day or two after injection, particularly early in treatment or after a dose increase. They are not a sign that something has gone wrong; they reflect the medicine doing exactly what it is designed to do at peak concentration. For most people these sensations settle within a few days as the level naturally begins to taper.

The NHS tirzepatide medicines page describes the most common side effects and when they typically arise, which is worth reading alongside the Patient Information Leaflet included with your pen.

Step 2: days two through seven — the sustained activity window

Because tirzepatide's half-life is around five days, drug levels fall only gradually after the peak. By day seven, enough remains in your system to maintain meaningful receptor activity. This is the pharmacological rationale for once-weekly dosing: you are not starting from zero each time you inject. The trough level on day seven (just before the next dose) is still pharmacologically relevant, which keeps the appetite and metabolic effects broadly consistent across the week.

For people new to the medicine, a common misconception is that tirzepatide works like a short-acting appetite suppressant — something you feel on injection day and lose by the weekend. If you want to understand how long tirzepatide's effects actually last across the week, the sustained half-life means the effect is spread across all seven days, so the hunger reduction you notice on Thursday is still the same injection you gave yourself on Sunday.

You can read more about how the medicine's receptor mechanism produces these effects on our Mounjaro mode of action page, which covers the GIP and GLP-1 pathway in plain terms.

Step 3: reaching steady state, why weeks three to four feel different

With a half-life of roughly five days and dosing every seven days, tirzepatide accumulates in the body over repeated injections. Full steady state (where the amount entering your system each week equals the amount cleared) is generally reached after about four weekly doses. This matters because the appetite and metabolic effects you experience in weeks three and four are stronger and more consistent than what you felt after the first injection, even at the same dose.

The four-week titration schedule that prescribers follow is built around this accumulation curve. Moving from one dose to the next too quickly, before steady state is reached, makes it harder to judge how well a given dose is working and increases the chance of avoidable side effects. The schedule is set out in the Mounjaro SmPC on the eMC (Electronic Medicines Compendium), which is the authoritative reference for exact dosing intervals.

If you are curious how your current dose position fits your wider treatment plan, our tirzepatide onset of action page covers the early-treatment timeline in more detail.

Step 4: what happens if the interval is broken, missed doses and washout

The long duration of action gives tirzepatide some practical flexibility around missed doses, but it is not unlimited. A dose taken up to four days after the usual day can still be used; if more than four days have passed, that dose should be skipped and the next taken on the regular scheduled day. Never take two doses to compensate. Beyond the short-term question of a single missed injection, it is useful to understand the washout period: our page on tirzepatide duration explains how, after stopping entirely, meaningful pharmacological activity can persist for several weeks given the five-day half-life, approximately five half-lives, or roughly 25 days, for the majority of the drug to clear.

This washout has clinical relevance in specific situations. Planned surgery is one: NHS guidance recommends informing the anaesthetist that you take a GLP-1 or dual agonist medicine, because of the potential effect on gastric emptying under anaesthesia. Questions about surgery timing are always deferred to your prescriber. The same applies to the contraception interaction for tirzepatide, and if you want a clearer picture of how tirzepatide's action affects absorption of other medicines, oral contraceptive absorption may be affected during the first four weeks of treatment and after each dose increase, which is why a non-oral backup method is typically advised during those windows per NHS England's guidance on weight management injections.

For a broader overview of the treatment and its place in a weight management plan, our tirzepatide overview brings together eligibility, results evidence, and access routes in one place. If cost is on your mind, our guide to Mounjaro pricing in the UK covers what private treatment actually includes and why the cheapest listing is not always the safest one.

Ready to talk through whether tirzepatide suits your situation? Check your eligibility with our clinical team, consultations are free, and a GPhC-registered prescriber reviews your answers the same day.